D. E. Shaw & Co., Inc. Night Hawk Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.65 - $3.13 $29,172 - $55,338	-17,680 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.1 - $3.54 $56,752 - $95,668	-27,025 Reduced 60.45%	17,680 $54,000
Q4 2021 Feb 14, 2022	SELL	$3.04 - $6.01 $78,222 - $154,643	-25,731 Reduced 36.53%	44,705 $136,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $303,560 - $382,795	51,451 Added 271.01%	70,436 $419,000
Q2 2021 Aug 16, 2021	BUY	$5.78 - $9.6 $109,733 - $182,256	18,985 New	18,985 $128,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.